CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
REVENUES:
REVENUES	$ 18,816,611	$ 8,724,359
COSTS AND EXPENSES:
Cost of product revenue	15,223,861	3,548,441
Research and development expenses	1,653,706	2,863,338
Selling, general and administrative expenses	6,946,271	6,085,067
Impairment, restructuring, severance and related costs	3,043,179	83,087
TOTAL COSTS AND EXPENSES	26,867,017	12,579,933
LOSS FROM OPERATIONS	(8,050,406)	(3,855,574)
OTHER EXPENSE:
Interest expense, net	(733,561)	(712,477)
LOSS BEFORE INCOME TAXES	(8,783,967)	(4,568,051)
Income tax (expense)/benefit	(6,327)	67,888
NET LOSS	$ (8,790,294)	$ (4,500,163)
Basic loss per share (in dollars per share)	$ (0.29)	$ (0.22)
Diluted loss per share (in dollars per share)	$ (0.29)	$ (0.22)
Weighted average number of shares outstanding, basic (in shares)	30,090,045	20,163,386
Weighted average number of shares outstanding, diluted (in shares)	30,090,045	20,163,386
Product Revenue [Member]
REVENUES:
REVENUES	$ 18,527,456	$ 4,024,662
R&D Revenue [Member]
REVENUES:
REVENUES	18,173	1,106,639
Government Grant Income [Member]
REVENUES:
REVENUES	0	3,350,000
License and Royalty Revenue [Member]
REVENUES:
REVENUES	$ 270,982	$ 243,058